FDA Adverse Event Injury Summary report: N

HEARTMATE XVE LVAS

MDR report key: 1172073 · Received September 23, 2008

Report

Report Number
2916596-2008-00133
Event Type
Injury
Date Received
September 23, 2008
Date of Event
August 25, 2008
Report Date
August 25, 2008
Manufacturer
THORATEC CORP.
Product Code
DSQ
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

PATIENT REMAINS ONGOING WITH THE LVAD. THE EXPLANTED DEVICE WAS SENT TO THE MANUFACTURER FOR EVALUATION. NO FURTHER INFORMATION IS AVAILABLE AT THIS TIME. A SUPPLEMENTAL REPORT WILL BE SUBMITTED WHEN THE DEVICE ANALYSIS IS COMPLETED.

Description of Event or Problem · 1

THE PATIENT WAS IMPLANTED WITH A VENTED ELECTRIC LEFT VENTRICULAR ASSIST DEVICE (LVAD). IT WAS REPORTED BY THE RESEARCH COORDINATOR THAT WHEN THE PATIENT LIFTED A GAS CAN HE "FELT SOMETHING PULL" IN HIS ABDOMEN AROUND THE PUMP AND DRIVELINE. THAT AREA HAD PULLED OPEN, AND SOME BLEEDING OCCURRED. TWO DAYS LATER, THE PATIENT CALLED THE HOSPITAL TO REPORT THE EVENT AND WAS INSTRUCTED TO GO INTO THE CLINIC. THE PATIENT HAD CULTURES TAKEN AND AN INFECTION WAS FOUND. THE PATIENT WAS ADMITTED AND TREATED FOR THE INFECTION AND DEBRIDEMENT OF THE PUMP POCKET. A COUPLE OF WEEKS LATER, AFTER NEGATIVE CULTURES WERE OBTAINED, THE PATIENT WAS DISCHARGED. ANTIBIOTICS WERE CONTINUED ALONG WITH CHANGE OF DRESSINGS FOR THE WOUND, AND THE PATIENT WAS MONITORED. APPROXIMATELY 4 MONTHS LATER, THE PATIENT REPORTED INCREASING DRAINAGE FROM HIS WOUND AND THAT THE PUMP WAS EASILY VISIBLE. THE RESEARCH COORDINATOR REPORTED THAT ALTHOUGH THE PATIENT WAS NOT HARMED BY THE REPORTED EVENT, THE POTENTIAL FOR SEPSIS REMAINED, AND AS A RESULT, A DECISION WAS MADE TO EXCHANGE THE PUMP, AND THE PATIENT'S LVAD WAS REPLACED WITH ANOTHER LVAD. THE PATIENT REMAINS ONGOING WITH THE LVAD.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 HEARTMATE XVE LVAS LEFT VENTRICULAR ASSIST DEVICE DSQ THORATEC CORP. 1270

Patients

Seq Age Sex Outcome Treatment
1 59 YR Required Intervention